Peer-reviewedCC BYDiagnostics (Basel, Switzerland)
Toward a National Tuberculosis Lateral-Flow Urine Lipoarabinomannan (LF-LAM) External Quality Assessment Program in Thailand: Feasibility Demonstration Through Panel Development, Validation, and Proficiency Testing, March 2025–April 2026
4 affiliations
- 1Department of Medical Sciences, , Nonthaburi 11000, Thailand; (P.U.); (S.J.); (K.N.); (N.S.); (T.K.); (P.T.); (L.T.); (C.K.); (P.A.O.); (S.B.)
- 2Division of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Nonthaburi 11000, Thailand; (T.T.); (S.N.); (R.L.); (S.N.)
- 3Department of Thai Traditional and Alternative Medicine, , Nonthaburi 11000, Thailand; (S.P.C.); (W.T.)
- 4Clinical Immunology Laboratory, Department of Pathology, Faculty of Medicine Ramathibodhi Hospital, , Bangkok 10400, Thailand;
Related
- ROBECS one: feasibility study of a structured robotic curriculum and a proficiency-based framework
- Evaluating the acceptability, feasibility, and implementation fidelity of a multipurpose mobile health (mHealth) app used for Tuberculosis (TB) contact tracing by Ward-Based Outreach Teams (WBOTs) in South Africa
- An Artificial Intelligence Supervision Program to Improve Video-Observed Therapy for Managing Tuberculosis Treatment: Development and Validation Study
- Prospective field deployment of Swaasa® AI for community-based screening of tuberculosis and other respiratory diseases in Andhra Pradesh: a feasibility and implementation study
- The Master Adaptive Learner Behavioral Assessment Scale (MAL BAS): Development, Validity Evidence, Feasibility, and Acceptability of a New Instrument
BibTeX
@article{suparak2026toward,
title = {{Toward a National Tuberculosis Lateral-Flow Urine Lipoarabinomannan (LF-LAM) External Quality Assessment Program in Thailand: Feasibility Demonstration Through Panel Development, Validation, and Proficiency Testing, March 2025–April 2026}},
author = {Supaporn Suparak and Theerawit Tasaneeyapan and Petai Unpol and Sirilada Pimpa Chisholm and Siriphailin Jomjunyoung and Kanokwan Ngueanchanthong and Wipawee Thanyacharern and Nitis Smanthong and Thanapatra Klawech and Phitchamon Thongthirach and Laddawan Thiemsing and Chonthicha Kawidam and Chavachol Setthaudom and Somboon Nookhai and Rangsima Lolekha and Pilailuk Akkapaiboon Okada and Sarawut Boonsuk and Sanny Northbrook},
journal = {Diagnostics (Basel, Switzerland)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13702989},
note = {CC BY},
}
RIS
TY - JOUR
TI - Toward a National Tuberculosis Lateral-Flow Urine Lipoarabinomannan (LF-LAM) External Quality Assessment Program in Thailand: Feasibility Demonstration Through Panel Development, Validation, and Proficiency Testing, March 2025–April 2026
AU - Supaporn Suparak
AU - Theerawit Tasaneeyapan
AU - Petai Unpol
AU - Sirilada Pimpa Chisholm
AU - Siriphailin Jomjunyoung
AU - Kanokwan Ngueanchanthong
AU - Wipawee Thanyacharern
AU - Nitis Smanthong
AU - Thanapatra Klawech
AU - Phitchamon Thongthirach
AU - Laddawan Thiemsing
AU - Chonthicha Kawidam
AU - Chavachol Setthaudom
AU - Somboon Nookhai
AU - Rangsima Lolekha
AU - Pilailuk Akkapaiboon Okada
AU - Sarawut Boonsuk
AU - Sanny Northbrook
PY - 2026
DA - 2026/10/01
JO - Diagnostics (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13702989
SN - 2075-4418
ER -